Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors

Stem Cells Translational Medicine

Volumn 2, Issue 6, 2013, Pages 473-479

  Theka, Ilda ^a   Caiazzo, Massimiliano ^a   Dvoretskova, Elena ^b   Leo, Damiana ^b   Ungaro, Federica ^a   Curreli, Sebastiano ^b   Managò, Francesca ^b   Dell'Anno, Maria Teresa ^a   Pezzoli, Gianni ^c   Gainetdinov, Raul R ^b   Dityatev, Alexander ^b   Broccoli, Vania ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c PARKINSON INSTITUTE   (Italy)

Author keywords

Direct cell conversion; Dopamine; Neuron; Pluripotent stem cells; Reprogramming

Indexed keywords

4', 6 DIAMIDINO 2 PHENYLINDOLE; DOPAMINE; DOXYCYCLINE; GREEN FLUORESCENT PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3BETA; MICROTUBULE ASSOCIATED PROTEIN 2; NUCLEAR RECEPTOR RELATED FACTOR 1; TRANSCRIPTION FACTOR MASH1; TRANSCRIPTION FACTOR PITX3; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; ELECTRIC ACTIVITY; ELECTROPHYSIOLOGY; FIBROBLAST; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NUCLEAR REPROGRAMMING; PARKINSON DISEASE; PLURIPOTENT STEM CELL; VIRAL GENE DELIVERY SYSTEM;

EID: 84878759743     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0133     Document Type: Article

References (24)

1. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet 2009;373:2055-2066.
2. Hardy J, Lewis P, Revesz T et al. The genetics of Parkinson's disease syndromes: A critical review. Curr Opin Genet Dev 2009;19:254-265.
3. Dauer W, Przedborski S. Parkinson's disease: Mechanisms and models. Neuron 2003; 39:889-909.
4. Dawson TM, Kho HS, Dawson VL et al. Genetic animal models of Parkinson's disease. Neuron 2010;66:646-661.
5. Gomez-Santos C, Ferrer I, Santidrian AF et al. Dopamine induces autophagic cell death and alpha-synuclein increase in human neuro-blastoma SH-SY5Y cells. J Neurosci Res 2003; 73:341-350.
6. Bjorklund A, Dunnet SB. Dopamine neuron system in the brain: An update. Trends Neurosci 2007;30:194-202.
7. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872.
8. Nakagawa M, Koyanagi M, Tanabe K et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibro-blasts. Nat Biotechnol 2008;26:101-106.
9. Marchetto MC, Carromeu C, Acab A et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010;143: 527-539.
10. Cooper O, Hargus G, Deleidi M et al. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionaliza-tion by retinoic acid. Mol Cell Neurosci 2010; 45:258-266.
11. Nguyen HN, Byers B, Cord B et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 2011;8:267-280.
12. Devine MJ, Ryten M, Vodicka P et al. Parkinson's disease induced pluripotent stem cells with triplication of the a-synuclein locus. Nat Commun 2011;2:440.
13. Lee SH, Lumelsky N, Studer L et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000;18:675-679.
14. Perrier AL, Tabar V, Barberi T et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 2004;101:12543-12548.
15. Cho MS, Hwang DY, Kim DW et al. Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale. Nat Protoc 2008;3:1888-1894.
16. Martinat C, Bacci JJ, Leete T et al. Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci USA2006;103: 2874-2879.
17. Sanchez-Danes A, Consiglio A, Richaud Y et al. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of Lmx1a in human embryonic stem cells and iPS cells. Hum Gene Ther 2012;23:56-69.
18. Chambers SM, Fasano CA, Papapetrou EP et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009;27:275-280.
19. Cai J, Yang M, Poremsky E et al. Dopami-nergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev 2010;19:1017-1023.
20. Caiazzo M, Dell'Anno MT, Dvoretskova E et al. Direct generation of functional dopami-nergic neurons from mouse and human fibro-blasts. Nature 2011;476:224-227.
21. Kim J, Su SC, Wang H et al. Functional integration of dopaminergic neurons directly converted form mouse fibroblasts. Cell Stem Cell 2011;9:413-419.
22. Watanabe K, Ueno M, Kamiya D et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 2007;25:681-686.
23. Roy NS, Cleren C, Singh SK et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astro-cytes. Nat Med 2006;12:1259-1268.
24. Sonntag KC, Pruszak J, Yoshizaki T et al. Enhanced yield of neuroepitelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 2007;25:411-418.